In 2023, Kenneth Reali earned $1.32M in total compensation at Bioventus, including $193.15K salary and $548.81K bonus. Most recently sold 9,811 shares in Mar 2022. Currently holds stock worth $279.77K. Led Bioventus as CEO for 3 years.
Compensation History
Annual executive compensation data for Kenneth Reali, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.32M
Salary
$193.15K
Bonus
$548.81K
Other
$578.01K
Salary
$193.15KBoard Justification
The compensation philosophy is designed to align executive compensation with company performance and retention strategies, ensuring that executives are rewarded for achieving key performance metrics.
Bonus
$548.81KBoard Justification
The bonus includes a 2023 component paid as part of Mr. Reali’s separation agreement.
Other Compensation
$578.01KBoard Justification
Other compensation includes severance payments and COBRA payments made in connection with Mr. Reali’s separation from the Company.
Restricted Stock
Board Justification
No stock awards vested in 2023 as Mr. Reali's employment ended before any stock grants could vest.
Performance Metrics
Performance metrics for the CEO's compensation are based on the achievement of corporate and personal performance objectives.
Kenneth Reali
Ex-CEO of Bioventus
Education
Bachelor of Science in Business Administration from Valparaiso University
Field of Expertise
Business & Management
Sector of Economy
Healthcare
CEO of Bioventus for
3 years 0 months (Apr 2020 - Apr 2023)
Previous Experience
President and CEO of Clinical Innovations, LLC
Other Bioventus CEOs
Holdings
Track Kenneth Reali's stock holdings and portfolio value over time.
Total Stock Sold
$15.99K
$15.99K
9,811 BVS shares
What if they kept their stock?
If Kenneth Reali didn't sell their stock, today they would have:
Extra BVS9,811 shares worth $69.56K.
This is 334.97% and $53.57K more than what they got when they sold the stock.
Insider Trading
Kenneth Reali's recent stock transactions, purchases, and sales filed with the SEC.
$13.62K
BVS at $1.39/share
Mar 14, 2022
Sale
$26.66K
BVS at $14.81/share
Sep 9, 2021
Purchase
$121.88K
BVS at $13.00/share
Feb 11, 2021
Purchase
Rivals
Compare Kenneth Reali with competitor CEOs and industry peers.